Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.48 | N/A |
| PEG Ratio (TTM) | -1.14 | N/A |
| P/S Ratio (TTM) | 1.19 | N/A |
| P/B Ratio (TTM) | 3.00 | N/A |
| P/FCF Ratio (TTM) | -32.94 | N/A |
| Price to 5YR AVG Earnings Ratio | 21.37 | N/A |
| Price to 5YR AVG FCF Ratio | -14.62 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.97% | N/A |
| ROE (TTM) | 25.46% | N/A |
| Net Profit Margin (TTM) | 9.47% | N/A |
| ROIC 5YR AVG | -2.14% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.12% | 53.03% | 61.64% |
| Revenue | -0.96% | -4.52% | 4.32% |
| Net Income | -5.06% | 53.92% | 61.62% |
| Cash Flow | 6.72% | 3.16% | 11.92% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.49 | N/A |
| Quick Ratio (TTM) | 1.37 | N/A |
| D/E Ratio (TTM) | 2.55 | N/A |
| Interest Coverage (TTM) | 3.52 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.53 | N/A |
| LTL to 5YR AVG FCF | -13.02 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.24% | N/A |